Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study reveals sex-specific cognitive effects of astrocytic receptors

Study reveals sex-specific cognitive effects of astrocytic receptors

Older adults with a criminal background found to have higher risk of developing dementia

Older adults with a criminal background found to have higher risk of developing dementia

Memory decline reported by patients and partners may signal early Alzheimer's changes

Memory decline reported by patients and partners may signal early Alzheimer's changes

Self-reported memory problems and partner confirmation may signal tau buildup in the brain

Self-reported memory problems and partner confirmation may signal tau buildup in the brain

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

New help for dealing with aggression in people with dementia

New help for dealing with aggression in people with dementia

Researchers identify novel way to potentially slow down or halt Alzheimer’s progression

Researchers identify novel way to potentially slow down or halt Alzheimer’s progression

Phytochemicals show promise in treating neurological disorders by influencing the gut-brain axis

Phytochemicals show promise in treating neurological disorders by influencing the gut-brain axis

Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

Study offers insights into factors influencing older adults to stop driving

Study offers insights into factors influencing older adults to stop driving

Breakthrough study reveals molecular drivers of Alzheimer's progression

Breakthrough study reveals molecular drivers of Alzheimer's progression

Cognitive decline predicts driving cessation in seniors

Cognitive decline predicts driving cessation in seniors

Australian scientists explore how harmful bacteria contribute to Alzheimer's

Australian scientists explore how harmful bacteria contribute to Alzheimer's

Understanding the role of oxidative stress in Alzheimer's disease pathogenesis

Understanding the role of oxidative stress in Alzheimer's disease pathogenesis

Scientists uncover protein folding secrets through sound

Scientists uncover protein folding secrets through sound

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

World's first human mini-brain with a fully functional blood-brain barrier developed

World's first human mini-brain with a fully functional blood-brain barrier developed

Study confirms strong barrier preventing chronic wasting disease transmission to humans

Study confirms strong barrier preventing chronic wasting disease transmission to humans

Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

New therapy shows greater weight loss in mice by targeting brain's appetite center

New therapy shows greater weight loss in mice by targeting brain's appetite center

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.